| ¿µ¹® | acetabular index | ÇÑ±Û | Àý±¸Áö¼ö, °ü°ñ±¸Áö¼ö |
|---|---|---|---|
| ¼³¸í | ¿ø·¡ Àý±¸´Â °ñ¹ÝÀÇ 3°³ÀÇ »À. Áï ¾ûµ¢»À, µÎµ¢»À, ±ÃµÕ»À·Î ¸¸µé¾îÁö´Â µ¥ ¼Ò¾Æ¿¡¼± ¾ÆÁ÷ ¿ÏÀüÇÑ »ÀµÇ±â°¡ ÀϾÁö ¾Ê¾Æ¼ ÀÌ ºÎºÐÀÌ »ï¹æ¿¬°ñÀý±¸·Î ¿¬°áµÇ¾î ÀÖ´Ù. ÀÌ »ï¹æ¿¬°ñÀ» ¿¬°áÇÑ ¼±°ú Àý±¸°¡Âʳ¡°ú »ï¹æ¿¬°ñÀÇ ¾ÈÂÊÀ» ¿¬°áÇÑ ¼±°úÀÇ °¢À» ¸»ÇÑ´Ù. ÀÌ °¢ÀÌ 40µµ ÀÌ»óÀ̸é Àý±¸ÀÇ ÀÌ»ó ¹ßÀ°À» ÀǹÌÇÑ´Ù. |
||
| ¿µ¹® | brain death | ÇÑ±Û | ³ú»ç |
|---|---|---|---|
| ¼³¸í | ³ú±â´ÉÀÌ ¿ÏÀüÈ÷ Á¤ÁöµÇ¾î ȸº¹ ºÒ´ÉÇÑ »óÅÂ. ³úÀÇ ±â´É¿¡´Â ´ë³ú¹Ý±¸ÀÇ ±â´É À̿ܿ¡ ³ú°£ÀÇ ±â´Éµµ Æ÷ÇԵȴÙ. ³ú»ç´Â Àΰ£ÀÇ Á×À½°ú °°Àº ¶æÀÌ ¾Æ´Ï°í, º¸ÅëÀº ³ú»ç ´ÙÀ½¿¡ Á×À½ÀÌ ¿Â´Ù. ½ÉÀåÀÌ½Ä ¼ö¼ú¿¡´Â °¡´ÉÇÑ ÇÑ ½Å¼±ÇÑ ½ÉÀåÀÌ ÇÊ¿äÇϱ⠶§¹®¿¡ ½ÉÀå Á¦°øÀÚÀÇ Á×À½À» ³ú»ç·Î ±ÔÁ¤ÇÏ·Á´Â ¿òÁ÷ÀÓÀÌ ÀÖ¾ú´Ù. 1968³â 8¿ù ¼¼°èÀÇ»çȸ ÃÑȸ¿¡¼ äÅÃµÈ Àå±âÀ̽Ŀ¡ °üÇÑ ¼±¾ð(½Ãµå´Ï ¼±¾ð)¿¡¼´Â ¨ç ½ÉÀå Á¦°øÀÚÀÇ Á×À½ÀÇ ÆÇÁ¤Àº ³úÆÄÃøÁ¤»óÀÇ ³úÆÄÀÇ Á¤Áö(³ú»ç)·Î °áÁ¤ÇØ¾ß ÇÑ´Ù. ¨è Á¦°øÀÚÀÇ Á×À½À» È®ÀÎÇϴµ¥ µÎ¸íÀÌ»óÀÇ Àǻ簡 ÀÔÈ¸ÇØ¾ß Çϸç, ³ú»çÀÇ °áÁ¤¿¡ Âü¿©ÇÑ ÀÇ»ç´Â À̽ļö¼ú¿¡ °ü¿©Çؼ´Â ¾È µÈ´Ù°í Çß´Ù. ±×·¯³ª ³úÆÄÃøÁ¤¸¸À¸·Î´Â ³úÁÙ±âÀÇ ±â´ÉÁ¤Áö¸¦ ÆÇÁ¤ÇÒ ¼ö ¾ø°í, ³ú»çÀÇ ÆÇÁ¤µµ Áúº´ÀÇ Á¾·ù³ª Áøµµ¿¡ µû¶ó ±âÁØÀÌ ´Þ¶óÁö¹Ç·Î ÆÇÁ¤±âÁØÀÇ °ËÅä°¡ ÇÊ¿äÇÏ´Ù. ³úÁ¾¾ç-³ú¿Ü»ó-Ç÷ÇàÀå¾Ö µî ³úÁúȯÀÇ Áõ·Ê¿¡¼ º¸¸é ¨ç ±íÀº È¥¼ö, ¨è ¾çÂÊ µ¿°øÀÇ È®´ë ¹× µ¿°øÀÇ ºû¹Ý»ç¿Í °¢¸·¹Ý»çÀÇ ¼Ò½Ç, ¨é È£ÈíÀÇ Á¤Áö, ¨ê ³úÆÄÀÇ ÆòźÈ, ¨ë Ç÷¾ÐÀÇ ±Þ°ÝÇÑ ÀúÇÏ¿Í ±×¿¡ µû¸¥ ÀúÇ÷¾Ð µî ´Ù¼¸ °¡Áö Á¶°ÇÀÌ 6½Ã°£ ÈÄ¿¡µµ µ¿ÀÏÇÑ »óÅ¿¡ ÀÖ´Â °Í µî ¿©¼¸°¡Áö Á¶°ÇÀÌ ÆÇÁ¤ ±âÁØÀÌ µÇ¾ú¾ú´Ù. ÇöÀç´Â °¡Àå °·ÂÇÑ µ¿ÅëÀڱؿ¡ ´ëÇØ¼µµ ÀüÇô ¾Æ¹«·± °¨¼ö¼º°ú ¹ÝÀÀ¼ºÀ» ³ªÅ¸³»Áö ¾Ê´Â 24½Ã°£¿¡ °ÉÄ£ È¥¼ö·Î¼, Àڹ߿ ¶Ç´Â ÀÚ¹ßÈ£ÈíÀÌ ¾ø°í À¯¹ß¹Ý»ç°¡ ¼Ò½ÇµÇ°í ³úÀÇ Àü±âȰµ¿ÀÌ ¾ø¾îÁö´Â ȸº¹ºÒ°¡´ÉÇÑ ÀǽļҽÇÀ̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. |
||
| ¿µ¹® | death | ÇÑ±Û | »ç¸Á, Á×À½, »ç |
|---|---|---|---|
| ¼³¸í | 1. »ý¸íȰµ¿ÀÌ Á¤ÁöµÇ¾î ´Ù½Ã ¿ø»óÅ·Πµ¹¾Æ¿ÀÁö ¾Ê´Â »ý¹°ÀÇ »óÅÂ. »îÀÇ Á¾¸»À» ¸»ÇÑ´Ù. ¿¹¸¦ µé¾î ¾Æ¸Þ¹Ù µîÀÇ ´Ü¼¼Æ÷ »ý¹°¿¡¼´Â 2°³Ã¼·Î ºÐ¿µÉ ¶§°¡ Á×À½À̶ó°í ¸»ÇÒ ¼ö ÀÖÀ»Áö ¸ð¸£³ª ´Ù¼¼Æ÷ »ý¹°¿¡ À־ ¼¼Æ÷ºÐ¿Àº ´Ü¼øÇÑ ¼ºÀåÀÇ ÇÑ °úÁ¤ÀÌ´Ù. »ý¹°Àº »ý½Ä¼¼Æ÷¸¦ ¸Å°³·Î »ý¸íÀ» ¿µ¿øÈ÷ Á¸¼Ó½ÃŰ´Â °ÍÀ̶ó°í º¼ ¼ö ÀÖ´Ù. Àΰ£À» Æ÷ÇÔÇÑ °íµîµ¿¹°¿¡ ÇÑÁ¤ÇÑ´Ù°í Çϸé Á×À½À̶õ ±× °³Ã¼¸¦ ±¸¼ºÇÏ´Â ¸ðµç Á¶Á÷ ¼¼Æ÷ÀÇ »ýȰ±â´ÉÀÇ Á¤Áö¶ó°í ¸»ÇÒ ¼ö ÀÖ´Ù. µû¶ó¼, ±¹ºÎÀûÀÎ ÇÑ ºÎºÐÀÇ »ýȰ±â´ÉÀÇ Á¤Áö¸¸À¸·Î´Â Á×À½À̶ó°í ÇÒ ¼ö ¾ø´Ù. 2. »ç¶÷ÀÌ Á×À½. »ç¶÷ÀÇ Á×À½Àº ³× °³ÀÇ Ãø¸éÀÌ ÀÖ´Ù. Áï ¨ç À°Ã¼Àû Á×À½(biological death), ¨è ½É¸®Àû Á×À½(psychological death), ¨é »çȸÀû Á×À½(social death), ¨ê ¹®ÈÀû Á×À½(culture death)À¸·Î »ý°¢ÇÒ ¼ö ÀÖ´Ù. Àΰ£ÀÇ ÀÏ»ýÀº ´ÜÁö »ý¸íÀÇ ¿¬Àå »Ó ¾Æ´Ï¶ó ÁúÀû Ãø¸é¿¡¼ ½É¸®Àû, »çȸÀû, ¹®ÈÀûÀÎ Ãæ½ÇÇÔÀÌ ÇÊ¿äÇÏ´Ù. ±Ù³â¿¡ ÀÇ·á±â¼úÀÇ ´«ºÎ½Å ¹ß´Þ¿¡ µû¶ó¼ ´õ¿í »ýȰÀÇ ÁúÀÌ Áß¿ä½ÃµÇ°í ÀÖ´Ù. ÀϹÝÀûÀ¸·Î À°Ã¼ÀûÀÎ Á×À½ÀÇ Á¤ÀÇ´Â ¸ðµç »ýü±â´ÉÀÇ ¿µ±¸Àû Á¤Áö. Áï ¨ç Àüü³ú±â´É, ¨è È£Èí°èÀÇ Àڹ߱â´É, ¨é ¼øÈ¯°èÀÇ Àڹ߱â´É, ÀÌ ¸ðµç °ÍÀÇ ºñ°¡¿ªÀûÀ¸·Î Á¤ÁöµÇ¾úÀ½À» ¸»ÇÑ´Ù. |
||
| ¿µ¹® | sudden infant death syndrome | ÇÑ±Û | ¿µ¾Æ±Þ»çÁõÈıº |
|---|---|---|---|
| ¼³¸í | ÇÑ »ì ÀÌÇÏÀÇ °Ç°ÇÑ ¾Æ±â°¡ ¾Æ¹«·± Á¶ÁüÀ̳ª ¿øÀÎ ¾øÀÌ °©Àڱ⠻ç¸ÁÇßÀ» °æ¿ì¿¡ ³»¸®´Â Áø´ÜÀÌ´Ù. ÀÌ ÁõÈıºÀº »ýÈÄ 1~4°³¿ù »çÀÌ¿¡ °¡Àå ¸¹ÀÌ ¹ß»ýÇϸç, ´ëºÎºÐ ¹ã 10½Ã¿¡¼ ¿ÀÀü 10½Ã »çÀÌ¿¡ ¹ß»ýÇÑ´Ù. Á¶»êÇϰųª ºÎ¸ð°¡ Èí¿¬ÀÚÀÏ °æ¿ì, 20¼¼ ÀÌÇÏ »ê¸ðÀÇ ÃÊ»ê, ÀÓ½ÅÀü °Ç°°ü¸®¿¡ ¼ÒȦÇÑ »ê¸ð¿¡°Ô¼ ÅÂ¾î³ ¿µ¾Æ¿¡°Ô¼ ¸¹ÀÌ ¹ß»ýÇÑ´Ù. ÀÌ ÁõÈıºÀ¸·Î »ç¸ÁÇÑ ¿µ¾ÆÀÇ ÇüÁ¦ÀÏ °æ¿ì ÀϹÝÀûÀÎ ¿µ¾Æº¸´Ù °É¸± È®·üÀÌ ³ôÀº °ÍÀ¸·Î ¾Ë·ÁÁ® ÀÖ´Ù. |
||
| CI | cardiac index; cardiac insufficiency; cell immunity; cell inhibition; cephalic index; cerebral infar... |
|---|---|
| MI | first meiotic metaphase; maturation index; medical illustrator; medical informatics; medical inspect... |
| PI | first meiotic prophase; isoelectric point; pacing impulse; package insert; pancreatic insufficiency;... |
| ISI | infarct size index; initial slope index; injury severity index; Institute for Scientific Information... |
| RI | radiation intensity; radioactive isotope; radioimmunology; recession index; recombinant inbred [stra... |
| NDI | National Death Index |
|---|---|
| AICD | Activation induced cell death |
| BD | Brain Death |
| D | Death |
| DED | death effector domain |
ascites
| bibliography, national | A bibliography which lists all the books and other publications published, or distributed in significant quantity, in a particular country. Sometimes the term is used with respect to the new publications published within a specific period, and sometimes with respect to all those published within a lengthy period of many years. It is also used to indicate a bibliogrpaphy of publications about a country (whether written by its nationals or not) and those written in the language of the country as well as those published in it. (12 Dec 1998) |
|---|---|
| national academy of sciences | A united states organization of distinguished scientists and engineers established for the purpose of investigating and reporting upon any subject of art or science as requested by any department of government. The national research council organised by nas serves as the principal operating agency to stimulate and support research. (12 Dec 1998) |
| National Cancer Information Service | <address, organisation> National Cancer Institute, cancer Information Service, office of Cancer Communications, Building 31, Room 10A24, 9000 Rockville Pike, Bethesda, MD 20892 (27 Sep 1997) |
| national centre for health care technology | A centre in the public health service which coordinates and administers a program of research, demonstrations, and evaluations of medical technologies and assessments of health care technology. (12 Dec 1998) |
| national centre for health statistics | A centre in the public health service which is primarily concerned with the collection, analysis, and dissemination of health statistics on vital events and health activities to reflect the health status of people, health needs, and health resources. (12 Dec 1998) |
| national environmental policy act | A federal law enacted in 1969 that requires all federal agencies to consider and analyse the environmental impacts of any proposed action. NEPA requires an environmental impact statement for major federal actions significantly affecting the quality of the environment. NEPA requires federal agencies to inform and involve the public in the agency's decision making process and to consider the environmental impacts of the agency's decision. (05 Dec 1998) |
| National Formulary | An official compendium formerly issued by the American Pharmaceutical Association but now published by the United States Pharmacopeial Convention for the purpose of providing standards and specifications which can be used to evaluate the quality of pharmaceuticals and therapeutic agents. (05 Mar 2000) |
| national health planning information centre | A centre in the health resources administration division of planning methods and technology which provides access to current information on health planning and resources development. (12 Dec 1998) |
| national health programs | Components of a national health care system which administer specific services, e.g., national health insurance. (12 Dec 1998) |
| national institute for occupational safety and health | An institute of the centres for disease control and prevention which is responsible for assuring safe and healthful working conditions and for developing standards of safety and health. Research activities are carried out pertinent to these goals. (12 Dec 1998) |
| national institute of mental health | A component of the national institutes of health concerned with research, overall planning, promoting, and administering mental health programs and research. (12 Dec 1998) |
| National Institutes of Health | <organisation> A nonregulatory U.S. Federal agency which has oversight of research activities that the agency funds. (09 Oct 1997) |
| national library of medicine | An agency of the national institutes of health concerned with overall planning, promoting, and administering programs pertaining to various aspects of documentation and library services in the field of medicine. (12 Dec 1998) |
| national practitioner data bank | A databank established by the health care quality improvement act of 1986 authorizing the department of health and human services to collect and release information on the professional competence and conduct of physicians, dentists, nurses, and other health care practitioners. The data include adverse actions on physicians' malpractice, licensure, hospital privileges, concealing of pertinent information, and the like. (12 Dec 1998) |
| National Science Foundation | <organisation> A nonregulatory U.S. Federal agency which has oversight of biotechnology research activities that the agency funds. (09 Oct 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|